Advanced Accelerator Application SA (ADR) (NASDAQ:AAAP) has announced the expansion of its theranostic pipeline with the addition of NeoBOMB1, which it describes as a novel GRPR antagonist. The ...

Ion Beam Applications press release (OTCPK:IOBCF): FY positive Group REBIT of €6.4 million (FY22 €11.1 million). Total Group net loss of €9.1 million (2022: €6.1 million profit). Revenue of €428.72M ...

Hello and welcome to IBA’s Full Year 2024 Results Conference Call. I am Thomas Pevenage, Head of Investor Relations of IBA. As usual, you will find this presentation on the Investor Relations page of ...

Article ‘Count’ and ‘Share’ for Advanced Accelerator Applications SA based on listed parameters only. The articles listed below published by authors from Advanced Accelerator Applications SA, ...